Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Oxford Nanopore Technologies PLC

ONT.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Advanced Medical Equipment & Technology ·

UK Mid Cap Analyst: BUY

Last Close

$2.34

▲ +1.94%

Market Cap $2.28B · Vol 1.76M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$2.28B

Mid Cap

Div Yield

N/A

EPS Growth

+13.45%

YoY

RSI (14)

73.82

Momentum

Beta

0.96

vs Market

52W High

$2.59

11.89% below

52W Low

$1.29

79.64% above

Volume

1.76M

Avg 2.36M

P/B

2.68

Price-to-book

ROE

-24.01%

Return on equity

Free Float

56.92%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Oxford Nanopore Technologies PLC (ONT.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ONT.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.36%

+50.83%

+28.85%

+53.50%

YTD

+34.97%

+5.99%

-21.66%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$301.66M
Net Income	$-195,626,693.00
Revenue Growth (YoY)	+10.51%
Gross Margin	58.64%
Operating Margin	-64.49%
Net Profit Margin	-64.85%
ROE	-24.01%
ROA · ROIC	-20.50% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	5.51
P/B	2.68
P/FCF	N/A
EPS Growth	+13.45%
Outstanding Shares	977.51M

Technical Indicators

50-Day SMA	$1.77
200-Day SMA	$1.75
RSI (14)	73.82
Beta	0.96
52-Week High	$2.59
52-Week Low	$1.29

Volume Today	1.76M
Avg Daily Volume (30D)	2.36M
Relative Volume	0.75x
Volatility (10D)	77.47
Volatility (30D)	75.82
Free Float	56.92%

Analyst Consensus

BUY

Current Price $2.34

Mean Target $2.51

52W Low$1.29 52W High$2.59

Current

Target

$1.29 $2.59

Current Analyst target

+7.26% upside potential · 11 analysts

Identifiers

ExchangeLSE

FIGIBBG001SFWFL1

ISINGB00BP6S8Z30

CountryUnited Kingdom

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateMar 1, 2027

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc +1.63% DHR Danaher Corp +0.53% ISRG Intuitive Surgical Inc -0.55% BSX Boston Scientific Corp -2.94% EW Edwards Lifesciences Corp -1.15%

Company Profile

Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Company’s segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.